Determinants of Platelet Activation in Human Essential Hypertension
- 1 January 2004
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hypertension
- Vol. 43 (1), 64-70
- https://doi.org/10.1161/01.hyp.0000105109.44620.1b
Abstract
Experimental data suggest that oxidative stress might be enhanced in hypertension and contribute to platelet activation. We hypothesized that both oxidative stress and platelet activation could be related to the clinical characteristics of hypertensive patients. The urinary excretion of 11-dehydrothromboxane (TX) B 2 , reflecting in vivo platelet activation, was measured in 75 patients with mild to severe essential hypertension and 75 pair-matched, healthy controls. The urinary excretion of 8-iso-prostaglandin (PG) F 2α was determined as an index of in vivo lipid peroxidation. Urinary 11-dehydro-TXB 2 was significantly higher in essential hypertensives compared with controls. Although no statistically significant difference in urinary 8-iso-PGF 2α was observed between patients and controls, plasma vitamin C was lower and plasma homocysteine higher in hypertensive patients than in controls. Both urinary 11-dehydro-TXB 2 and 8-iso-PGF 2α were higher in patients with advanced hypertensive retinopathy compared with patients without retinopathy. Multivariate linear regression analysis identified urinary 8-iso-PGF 2α , plasma fibrinogen, homocysteine, and vitamin E as the only variables independently correlated with urinary 11-dehydro-TXB 2 . Logistic regression analysis showed that high urinary 8-iso-PGF 2α , plasma fibrinogen, and homocysteine, as well as low plasma vitamin E, advanced retinopathy, elevated diastolic blood pressure, and the absence of antihypertensive treatment, were predictors of high urinary 11-dehydro-TXB 2 . We demonstrated increased oxidative stress and persistent platelet activation in essential hypertensives with advanced vascular lesions. These findings might help identify hypertensive patients who are at increased risk of cardiovascular events and who might benefit from long-term antiplatelet therapy.Keywords
This publication has 14 references indexed in Scilit:
- Increased Superoxide Generation Is Associated With Pulmonary Hypertension in Fetal LambsCirculation Research, 2003
- Blood Pressure Increase and Incidence of Hypertension in Relation to Inflammation-Sensitive Plasma ProteinsArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Homocysteine and AtherothrombosisThe New England Journal of Medicine, 1998
- The oxidant stress of hyperhomocyst(e)inemia.JCI Insight, 1996
- Local Amplification of Platelet Function by 8-Epi Prostaglandin F2α Is Not Mediated by Thromboxane Receptor IsoformsPublished by Elsevier BV ,1996
- Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors.JCI Insight, 1992
- Prostacyclin and thromboxane biosynthesis in mild essential hypertension.Hypertension, 1990
- Thromboxane A2 synthesis in pregnancy-induced hypertensionThe Lancet, 1990
- Radioimmunoassay of 11-dehydrothromboxane B2 in human plasma and urineBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1987
- Hypertensive RetinopathyOphthalmology, 1982